These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7562770)

  • 1. Effects of dietary modification and fish oil supplementation on dyslipoproteinemia in pediatric systemic lupus erythematosus.
    Ilowite NT; Copperman N; Leicht T; Kwong T; Jacobson MS
    J Rheumatol; 1995 Jul; 22(7):1347-51. PubMed ID: 7562770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized study of the safety and efficacy of fish oil (omega-3 fatty acid) supplementation with dietary and exercise counseling for the treatment of antiretroviral therapy-associated hypertriglyceridemia.
    Wohl DA; Tien HC; Busby M; Cunningham C; Macintosh B; Napravnik S; Danan E; Donovan K; Hossenipour M; Simpson RJ
    Clin Infect Dis; 2005 Nov; 41(10):1498-504. PubMed ID: 16231263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fish oil treatment of hyperlipidemia in children and adolescents receiving renal replacement therapy.
    Goren A; Stankiewicz H; Goldstein R; Drukker A
    Pediatrics; 1991 Aug; 88(2):265-8. PubMed ID: 1861924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The complex nature of the interaction between disease activity and therapy on the lipid profile in patients with pediatric systemic lupus erythematosus.
    Sarkissian T; Beyenne J; Feldman B; Adeli K; Silverman E
    Arthritis Rheum; 2006 Apr; 54(4):1283-90. PubMed ID: 16575849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Premature atherosclerosis in systemic lupus erythematosus.
    Ilowite NT
    J Rheumatol Suppl; 2000 Apr; 58():15-9. PubMed ID: 10782851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary treatment of hyperlipidemia in patients with systemic lupus erythematosus.
    Hearth-Holmes M; Baethge BA; Broadwell L; Wolf RE
    J Rheumatol; 1995 Mar; 22(3):450-4. PubMed ID: 7783060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal examination of lipid profiles in pediatric systemic lupus erythematosus.
    Sarkissian T; Beyene J; Feldman B; McCrindle B; Silverman ED
    Arthritis Rheum; 2007 Feb; 56(2):631-8. PubMed ID: 17265498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha/tumor necrosis factor receptor system in systemic lupus erythematosus.
    Svenungsson E; Gunnarsson I; Fei GZ; Lundberg IE; Klareskog L; Frostegård J
    Arthritis Rheum; 2003 Sep; 48(9):2533-40. PubMed ID: 13130473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of dyslipidemia in children and adolescents with systemic lupus erythematosus.
    Ardoin SP; Sandborg C; Schanberg LE
    Lupus; 2007; 16(8):618-26. PubMed ID: 17711898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longterm beneficial effect of chloroquine diphosphate on lipoprotein profile in lupus patients with and without steroid therapy.
    Borba EF; Bonfá E
    J Rheumatol; 2001 Apr; 28(4):780-5. PubMed ID: 11327250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of combined supplementation of fish oil with garlic pearls on the serum lipid profile in hypercholesterolemic subjects.
    Jeyaraj S; Shivaji G; Jeyaraj SD; Vengatesan A
    Indian Heart J; 2005; 57(4):327-31. PubMed ID: 16350679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postprandial triacylglycerolaemia: the effect of low-fat dietary treatment with and without fish oil supplementation.
    Roche HM; Gibney MJ
    Eur J Clin Nutr; 1996 Sep; 50(9):617-24. PubMed ID: 8880041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The lipid, lipoprotein, and apolipoprotein effects of hydroxychloroquine in patients with systemic lupus erythematosus.
    Hodis HN; Quismorio FP; Wickham E; Blankenhorn DH
    J Rheumatol; 1993 Apr; 20(4):661-5. PubMed ID: 8496861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of fish oil supplementation for treatment of moderate elevation of serum cholesterol.
    Valdini AF; Glenn MA; Greenblatt L; Steinhardt S
    J Fam Pract; 1990 Jan; 30(1):55-9. PubMed ID: 2403586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of lipid abnormalities in children with new-onset systemic lupus erythematosus.
    Tyrrell PN; Beyene J; Benseler SM; Sarkissian T; Silverman ED
    J Rheumatol; 2007 Oct; 34(10):2112-9. PubMed ID: 17787042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of modest doses of omega-3 fatty acids on lipids and lipoproteins in hypertriglyceridemic subjects. A randomized controlled trial.
    Deck C; Radack K
    Arch Intern Med; 1989 Aug; 149(8):1857-62. PubMed ID: 2669667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dyslipoproteinemia in pediatric systemic lupus erythematosus.
    Ilowite NT; Samuel P; Ginzler E; Jacobson MS
    Arthritis Rheum; 1988 Jul; 31(7):859-63. PubMed ID: 3134897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia.
    Mackness MI; Bhatnagar D; Durrington PN; Prais H; Haynes B; Morgan J; Borthwick L
    Eur J Clin Nutr; 1994 Dec; 48(12):859-65. PubMed ID: 7889894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a fish oil supplement on blood pressure and serum lipids in patients treated for coronary artery disease.
    Bairati I; Roy L; Meyer F
    Can J Cardiol; 1992; 8(1):41-6. PubMed ID: 1617510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent corticosteroid use and recent disease activity: independent determinants of coronary heart disease risk factors in systemic lupus erythematosus?
    Karp I; Abrahamowicz M; Fortin PR; Pilote L; Neville C; Pineau CA; Esdaile JM
    Arthritis Rheum; 2008 Feb; 59(2):169-75. PubMed ID: 18240259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.